The US Department of Health
and Human Services has been
commissioned to convene a Federal
Interagency Steering Committee to
establish a National Action Plan to
focus on adverse drug event (ADE)
prevention, according to a release
from the Joint Commission Journal
on Quality and Patient Safety.
The decision was made to
target three medication classes:
anticoagulants, diabetes agents
(insulin and oral hypoglycemic
agents), and opioids, the report
said.
One measure of the ADE Action
Plan’s success will relate to the
wider dissemination of information
and educational resources.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Aug 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.